US 9834520
Heterocyclic compound
granted A61PA61P1/04A61P1/06
Quick answer
US patent 9834520 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/04, A61P1/06, A61P11/06, A61P17/00